AI has moved from buzzword to boardroom priority, but scaling is proving harder than expected due to one silent saboteur: ...

Full-stack offerings introduced from AI models to agent development and application platforms and upgraded infrastructure ...

Begin redesigning now around human skills and phase out traditional hierarchies. Drill down and find out what your people ...

Not pressurising India would be to the transactional disadvantage of the US, because it would allow Russia and China to ...

Non-exclusive license for Solid Biosciences’ proprietary, next-generation myotropic capsid, AAV-SLB101, to accelerate development of KNA-155 for dysferlinopathySEATTLE--(BUSINESS WIRE)--Kinea Bio Inc.

Study says seven of ten pharma digital projects fail to deliver despite heavy spending: Our Bureau, Mumbai Thursday, September 25, 2025, 17:30 Hrs [IST] Seven out of ten digital p ...

This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit ...

Douglas Elliman (DOUG) shares could rebound despite recent mergers. Read here for insights on DOUG stock's potential upside ...

Non-exclusive license for Solid’s proprietary, next generation capsid, AAV-SLB101, to accelerate development of Kinea Bio’s gene therapy for ...

Golden Cross Resources (TSXV: AUX) (OTCQB: ZCRMF) is a Canadian mineral exploration company focused on advancing the Reedy ...

(NASDAQ: MDCX) is a clinical-stage biotech company working on disruptive approaches to cancer and urologic disease. The ...